Certificate record
NAD+, lot AS-NAD1000-3
Kovera Labs and/or ILS Labs assayed lot AS-NAD1000-3 of NAD+ from Ascend Science at 99.84% purity on 1 Sept 2026, reporting 1293.34 mg against a 1000 mg label, 29.3% above the labelled mass.
Assayed 1 Sept 2026 · Kovera Labs and/or ILS Labs · Ascend Science · record id coa-www-as-nad1000-3
What the certificate reports
| Compound | NAD+ |
|---|---|
| Lot identifier | AS-NAD1000-3 |
| Purity | 99.84% |
| Labelled mass | 1000 mg |
| Assayed mass | 1293.34 mg |
| Difference | 29.3% above the label |
| Assay date | 1 Sept 2026 |
| Testing laboratory | Kovera Labs and/or ILS Labs |
| Who commissioned it | Published by the vendor. Scored as a claim, not as corroboration — only an independently commissioned assay counts as verified. |
| Source document | https://www.ascend.science/product/nad-plus |
Check it yourself
Kovera Labs and/or ILS Labs does not publish a public lookup we have been able to find, so this certificate can be read but not independently re-pulled from the laboratory. The document above is the copy the vendor published. Where a laboratory does offer a lookup, we say so and link it.
A certificate describes the sample it names and nothing else. It is not a statement about any other lot, and it is not an endorsement of the vendor or of any use of the material.
Other lots from Ascend Science
- Semaglutide, lot AS-SEMA10 99.73% · 25 Sept 2026
- MOTS-c, lot AS-MS20-2 99.91% · 24 Sept 2026
- Sermorelin, lot AS-SERM5-2 99.73% · 1 Sept 2026
- Tirzepatide, lot AS-TZ10-2 99.83% · 24 Aug 2026
- Tesamorelin, lot AS-TSM5-2 99.48% · 24 Aug 2026
- Tirzepatide, lot AS-TZ20-2 99.7% · 24 Aug 2026
NAD+ from other vendors
- Origin Labs, lot Orig2609030820 99.99% · Freedom Diagnostics Testing
- Bench Grade Peptides, lot 00011/0011 99.82% · AV Analytics
- Next Gen Peptides, lot ND500-05 99.29% · ILS Laboratories
- Vial Drop Labs, lot VDL-20260827-BV5R 99.96% · KMD Analytical (KMD Group LLC)
- Next Gen Peptides, lot ND1-01 99.9% · ILS Laboratories
- Ascend Science, lot AS-NAD500-2 99.46% · Kovera Labs and/or ILS Labs